TABLE 1.
Total | Completed Subjects | Dropped Subjects | |
---|---|---|---|
No. of subjects | 367 | 311 | 56 |
Boys | 199 (54)a | 168 (54) | 31 (55) |
Race | |||
White | 278 (76) | 235 (76) | 43 (77) |
Black | 84 (23) | 72 (23) | 12 (21) |
Asian | 5 (1) | 4 (1) | 1 (2) |
Ethnicity | |||
Hispanic/Latino | 183 (50) | 159 (51) | 24 (43) |
Not Hispanic/Latino | 184 (50) | 152 (49) | 32 (57) |
TNF−308 polymorphism (363 tested) | 104 (29) | 89 (29) | 15 (31) |
IL-6–174 polymorphism (364 tested) | 163 (45) | 139 (45) | 24 (48) |
Patient months | 3436 | 3204 | 232 |
First 6 mo | 2078 | 1866 | 212 |
6–12 mo | 1358 | 1338 | 20 |
URI episodes | 887 (305)b | 859 (287) | 28 (19) |
First 6 mo | 605 | 577 | 28 |
6–12 mo | 283 | 283 | 0 |
AOM episodes | 180 (143) | 180 (143) | 0 (0) |
First 6 mo | 87 | 87 | 0 |
6–12 mo | 93 | 93 | 0 |
LRI episodes | 66 (51) | 66 (51) | 0 (0) |
First 6 mo | 38 | 38 | 0 |
6–12 mo | 28 | 28 | 0 |
No statistically significant difference in demographic and gene polymorphism data in completed subjects and dropped subjects.
Percentage of total.
Number of patients.